PROSTATE SPECIFIC ANTIGEN - A CRITICAL-ASSESSMENT OF THE MOST USEFUL TUMOR-MARKER FOR ADENOCARCINOMA OF THE PROSTATE

被引：1115

作者：

OESTERLING, JE

机构：

[1] Mayo Clinic, Rochester, MN 55905, 200 First St., S.W.

来源：

关键词：

PROSTATE; CARCINOMA; ADENOCARCINOMA; TUMOR MARKERS;

D O I：

10.1016/S0022-5347(17)38491-4

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：907 / 923

页数：17

共 116 条

[41] HUGHES HR, 1987, ANN CLIN BIOCH S1, V24, P206
[42] JOBSIS AC, 1978, CANCER, V41, P1788, DOI 10.1002/1097-0142(197805)41:5<1788::AID-CNCR2820410521>3.0.CO
[43] 2-D
[44] THE IMMUNOHISTOCHEMICAL DETECTION OF PROSTATIC ACID-PHOSPHATASE - ITS POSSIBILITIES AND LIMITATIONS IN TUMOR HISTOCHEMISTRY
JOBSIS, AC
DEVRIES, GP
MEIJER, AEFH
PLOEM, JS
[J]. HISTOCHEMICAL JOURNAL, 1981, 13 (06): : 961 - 973
[45] IDENTIFICATION OF RESIDUAL CANCER IN THE PROSTATE FOLLOWING RADIATION-THERAPY - ROLE OF TRANS-RECTAL ULTRASOUND GUIDED BIOPSY AND PROSTATE SPECIFIC ANTIGEN
KABALIN, JN
HODGE, KK
MCNEAL, JE
FREIHA, FS
STAMEY, TA
[J]. JOURNAL OF UROLOGY, 1989, 142 (02) : 326 - 331
[46] KILLIAN CS, 1985, CANCER RES, V45, P886
[47] KURIYAMA M, 1981, CANCER RES, V41, P3874
[48] KURIYAMA M, 1980, CANCER RES, V40, P4568
[49] LANGE PH, 1989, J UROLOGY, V141, P873
[50] LEE F, 1989, UROLOGY, V34, P4